Literature DB >> 11118103

Postshunt encephalopathy in liver transplanted children with portal vein thrombosis.

P Tissières1, D Pariente, C Chardot, F Gauthier, D Devictor, D Debray.   

Abstract

BACKGROUND: Surgical portosystemic shunting has been reported to alleviate successfully portal hypertension in liver transplanted recipients with portal vein thrombosis.
METHODS: We report two liver transplanted children with portal vein thrombosis who developed post-shunt acute encephalopathy. In one child, a mesocaval H-type shunt was created surgically because of bleeding related to Roux-en-Y loop varices at 3 months posttransplantation; in the other, a large spontaneous splenorenal shunt was discovered at the time of diagnosis of portal vein thrombosis on day 34 posttransplantation and was preserved.
RESULTS: Post-shunt encephalopathy developed 6 months and 2.7 years after transplantation, causing death in one child.
CONCLUSIONS: This report illustrates the risk and the possible dismal outcome of post-shunt encephalopathy in liver transplanted children. Therapeutic procedures other than portosystemic shunting that will restore an hepatopetal portal flow to the liver graft should be considered in liver-transplanted children with portal vein thrombosis.

Entities:  

Mesh:

Year:  2000        PMID: 11118103     DOI: 10.1097/00007890-200011270-00024

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  2 in total

1.  Impact of posttransplant portosystemic shunts on liver transplantation.

Authors:  Yukihiro Sanada; Koichi Mizuta; Taizen Urahashi; Taiichi Wakiya; Yoshiyuki Ihara; Noriki Okada; Naoya Yamada; Manabu Nakata; Yoshikazu Yasuda
Journal:  World J Surg       Date:  2012-10       Impact factor: 3.352

2.  Recurrent Hepatic Encephalopathy Due to Surgically Created Shunt During Living Donor Liver Transplantation.

Authors:  Narendra S Choudhary; Sanjiv Saigal; Neeraj Saraf; Sanjay S Baijal; Arvinder S Soin
Journal:  J Clin Exp Hepatol       Date:  2020-08-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.